Atlas Trials

Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals

Clinical trial NCT05267483 · UNKNOWN

Trial details

NCT number
NCT05267483
Sponsor
D'Or Institute for Research and Education
Status
UNKNOWN
Study type
OBSERVATIONAL
Sepsis
Start date
2022-04-01
Primary completion
2022-11-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.